Foresite Capital Management V, LLC

Q3 2026 13F-HR Holdings

Location
West Hollywood, CA
Holdings as of
9/30/2026
Date filed
11/16/2026
Form type
13F-HR
Num holdings
9
Total value ($000)
$289,148
Net value change ($000)
-73,054 (-20.2%)
New positions
1
Sold out positions
1
Turnover %
22.9%
Sector allocation + QoQ delta (equities-only)

Snapshot: Change Analysis

Compared to Q2 2026
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
Latigo Biotherapeutics, Inc. 59,502 NEW
NRIX 4,448 69.2%
Odyssey Therapeutics, Inc. 2,870 21.5%
HIMS 735 2.9%
Top Reduces (Value $000, Stocks/ETFs)
ALMS -122,362 -73.7%
LYEL -6,693 -100.0%
EIKN -6,608 -38.4%
IRON -2,872 -10.5%
PHVS -1,899 -8.3%
CGON -173 -0.2%
Instrument mix + QoQ Δ (ex-options)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type